Cargando…
E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
Targeted therapy has greatly improved both survival and prognosis of cancer patients. However, while therapeutic treatment of adenocarcinoma has been advanced greatly, progress in treatment of squamous cell carcinoma (SCC) has been slow and ineffective. Therefore, it is of great importance to deciph...
Autores principales: | Xu, Jing, Li, Fengtian, Gao, Ya, Guo, Rongtian, Ding, Liangping, Fu, Mengyuan, Yi, Yong, Chen, Hu, Xiao, Zhi-Xiong Jim, Niu, Mengmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032790/ https://www.ncbi.nlm.nih.gov/pubmed/33833226 http://dx.doi.org/10.1038/s41419-021-03662-3 |
Ejemplares similares
-
Correction: E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma
por: Xu, Jing, et al.
Publicado: (2022) -
Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis
por: Niu, Mengmeng, et al.
Publicado: (2021) -
Targeting of ΔNp63α by miR‐522 promotes the migration of breast epithelial cells
por: Dong, Yuanyuan, et al.
Publicado: (2021) -
ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis
por: Bergholz, Johann, et al.
Publicado: (2012) -
A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63
por: Panneerselvam, Jayabal, et al.
Publicado: (2013)